MARIA TOMARO: Open Payments
NPI 1477936870 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 14 payments from 13 companies in 2025. Trend: 2023 $118 · 2024 $175 · 2025 $476
Food & beverage: $381Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $97 |
| SEAGEN INC. | 1 | $95 |
| Intera Oncology, Inc | 1 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Exelixis Inc. | 1 | $27 |
| SOBI, INC | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $18 |
| Caris MPI, Inc. | 1 | $17 |
Products named: INTERA, KEYTRUDA, SCEMBLIX, CABOMETYX, Vonjo, ELZONRIS, PLUVICTO, Trodelvy.
Industry payments across OH — which companies pay providers there.
